cyclosporine has been researched along with adenosine in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 15 (34.09) | 18.2507 |
2000's | 12 (27.27) | 29.6817 |
2010's | 17 (38.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Auteri, JS; Hsu, D; Jeevanandam, V; Marboe, C; Rose, EA; Sanchez, JA; Smith, CR | 1 |
Bronsther, OL; Demetris, A; Fung, J; Pinna, AD; Rao, PN; Snyder, J; Starzl, TE | 1 |
Beck, Y; Ichikawa, N; Inoue, S; Meigata, K; Nagao, T; Nishimura, Y; Nomura, Y; Tomikawa, S; Uchida, H | 1 |
Chen, CS; Chen, HW; Chu, SH; Chuang, CK; Huang, CC; Lai, MK | 1 |
Babcock, GF; Bowlin, TL; Frondorf, KA; Stripp, SA; Wolos, JA | 1 |
Azoulay, D; Barbazza, F; Beaune, P; Bismuth, H; Bonhomme, L; Dennison, A; Dolizy, I; Gries, JM; Lemoine, A | 1 |
Peeters, J; Roels, L; Vanrenterghem, Y | 1 |
Claas, FH; De Meester, J; Persijn, GG; Smits, JM; Van Houwelingen, HC | 1 |
Carrier, M; Khalil, A; Latour, JG; Pelletier, LC | 1 |
Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
Bechis, G; Berland, YF; Brunet, P; Devaux, C; Dussol, B; Guieu, R; Rochat, H; Sampol, J | 1 |
Henneke, KH; Klauss, V; König, A; Meiser, B; Mudra, H; Regar, E; Reichart, B; Rieber, J; Spes, C; Theisen, K; Werner, F | 1 |
Kato, K; Li, ST; Zorumski, CF | 1 |
de Bruin, RW; Heemann, UW; Ijzermans, JN; Kouwenhoven, EA; Marquet, RL | 1 |
Berland, Y; Clot-Faybesse, O; Devaux, C; Dussol, B; Guieu, R; Halimi, G; Mercier, L; Rochat, H; Sampol, J | 1 |
Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
Arce, A; Esquifino, AI; Fideu, MD; Miras-Portugal, MT | 1 |
Cabrer, K; Fuster, J; García-Valdecasas, JC; González, FX; Grande, L; López-Boado, MA; Momblan, D; Rull, R; Vidal, O; Visa, J | 1 |
Baxter, GF; Hausenloy, DJ; Maddock, HL; Yellon, DM | 1 |
Mitchell, BS; Spychala, J | 1 |
Bakowski, D; Glitsch, MD; Parekh, AB | 1 |
Chou, YC; Chu, JJ; Chu, Y; Lin, PJ; Liu, HP; Wu, YC | 1 |
Duchen, M; Hausenloy, D; Wynne, A; Yellon, D | 1 |
Capecchi, PL; Carmellini, M; Collini, A; Guideri, F; Laghi-Pasini, F; Lazzerini, PE; Rechichi, S; Ruggieri, G | 1 |
Hung, LM; Ulusal, AE; Ulusal, BG; Wei, FC | 1 |
Braunstein, TH; Christensen, ML; Treiman, M | 1 |
Brault, A; Crenesse, D; Huet, PM; Laurens, M; Rocheleau, B; Tarrab, E | 1 |
Gao, S; Hu, M; Liu, W; Liu, Z; Wang, F; Yang, X; Yang, Z; Ye, L; Yin, T | 1 |
Balimane, PV; Frost, CE; Gan, J; Han, YH; He, K; Herbst, JJ; Humphreys, WG; Kolb, J; Shou, W; Wang, L; Zhang, D | 1 |
Amiot, BP; Glorioso, J; Liu, H; Mao, S; Nyberg, SL; Rinaldo, P; Rodysil, B; Yu, Y | 1 |
Chandna, M; Chandna, S; Dwarakanath, BS; Kumar, A; Pandey, A; Seth, RK; Singh, V; Suman, S | 1 |
Balsarotti, J; Briley, A; Dufner-Beattie, J; Noueiry, A; O'Guin, A; O'Guin, S; Olivo, PD; Rice, CM; Roth, R; Slomczynska, U; Starkey, G; Wang, B | 1 |
Bartos, JA; Debaty, G; Matsuura, T; Yannopoulos, D | 1 |
Hsia, J; Kujacic, M; Teng, R | 1 |
Andreadou, I; Dagres, N; Iliodromitis, EK; Iliodromitis, K | 1 |
Cai, J; Chen, ML; Chi, HJ; Dong, JL; Lin, XM; Qi, D; Sun, H; Yang, XC; Zhao, WS | 1 |
Botker, HE; Engstrom, T; Erlinge, D; Garcia-Dorado, D; Hausenloy, DJ; Heusch, G; Ibanez, B; Kloner, RA; Ovize, M; Yellon, DM | 1 |
de Klaver, PAG; van den Wall Bake, AWL; van Sloten, TT | 1 |
Cui, M; Gu, Z; Liu, X; Shen, L; Zhang, C | 1 |
3 review(s) available for cyclosporine and adenosine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Post-conditioning to improve cardiopulmonary resuscitation.
Topics: Adenosine; Analgesics, Opioid; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Cyclosporine; Guanidines; Humans; Mitochondria, Heart; Myocardial Reperfusion Injury; Out-of-Hospital Cardiac Arrest; Reactive Oxygen Species; Risk Assessment; Sulfones; Survival Analysis; Time Factors; Treatment Outcome | 2014 |
Progress in Therapies for Myocardial Ischemia Reperfusion Injury.
Topics: Adenosine; Animals; Atrial Natriuretic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Disease Models, Animal; Exenatide; Humans; Ischemic Postconditioning; Ischemic Preconditioning; Myocardial Ischemia; Myocardial Reperfusion Injury; Peptides; Venoms | 2017 |
1 trial(s) available for cyclosporine and adenosine
Article | Year |
---|---|
Pharmacokinetic interaction study of ticagrelor and cyclosporine in healthy volunteers.
Topics: Adenosine; Adult; Cross-Over Studies; Cyclosporine; Drug Interactions; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Purinergic P2Y Receptor Antagonists; Ticagrelor; Young Adult | 2014 |
40 other study(ies) available for cyclosporine and adenosine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Cardiac transplantation after prolonged graft preservation with the University of Wisconsin solution.
Topics: Adenosine; Allopurinol; Animals; Antilymphocyte Serum; Cardioplegic Solutions; Cyclosporine; Glutathione; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Insulin; Organ Preservation; Organ Preservation Solutions; Papio; Raffinose; Solutions; T-Lymphocytes; Time Factors | 1992 |
Prediction of early graft function by effluent levels of hyaluronic acid in clinical liver transplantation.
Topics: Adenosine; Allopurinol; Biomarkers; Cyclosporine; False Negative Reactions; False Positive Reactions; Glutathione; Graft Survival; Humans; Hyaluronic Acid; Insulin; Liver; Liver Transplantation; Methylprednisolone; Organ Preservation; Organ Preservation Solutions; Prognosis; Raffinose; Reperfusion; Solutions; Steroids; Tacrolimus | 1993 |
Auxiliary liver transplantation in beagles.
Topics: Adenosine; Alanine Transaminase; Allopurinol; Animals; Bilirubin; Cyclosporine; Dogs; Glutathione; Hepatectomy; Insulin; Liver Transplantation; Organ Preservation Solutions; Organ Size; Perfusion; Raffinose | 1994 |
Comparison of University of Wisconsin solution and University of Rochester (modified Collins) solution for renal preservation in renal transplantation.
Topics: Adenosine; Allopurinol; Cadaver; Cyclosporine; Glutathione; Graft Survival; Humans; Hypertonic Solutions; Insulin; Ischemia; Kidney; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Organ Preservation; Organ Preservation Solutions; Raffinose; Time Factors; Tissue Donors | 1994 |
Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses.
Topics: Adenosine; Adenosylhomocysteinase; Animals; Cyclosporine; Disease Models, Animal; Drug Evaluation, Preclinical; Graft Rejection; Graft Survival; Hydrolases; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Skin Transplantation; T-Lymphocytes | 1993 |
Relationship between cytochrome P-450 3A content of orthotopically transplanted liver and postoperative morbidity.
Topics: Adenosine; Adult; Allopurinol; Biomarkers; Cyclosporine; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Female; Glutathione; Humans; Insulin; Liver; Liver Transplantation; Male; Middle Aged; Mixed Function Oxygenases; Morbidity; Organ Preservation; Organ Preservation Solutions; Postoperative Complications; Raffinose; Tissue Donors | 1993 |
Delayed graft function as principal correlate of kidney allograft outcome in a single-center multivariate analysis.
Topics: Actuarial Analysis; Adenosine; Adult; Age Factors; Allopurinol; Cadaver; Cyclosporine; Female; Glucose; Glutathione; Graft Survival; Humans; Hypertonic Solutions; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Mannitol; Middle Aged; Multivariate Analysis; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Regression Analysis; Sex Factors; Time Factors; Tissue Donors; Treatment Outcome | 1996 |
The outcome of kidney grafts from multiorgan donors and kidney only donors.
Topics: Adenosine; Adult; Allopurinol; Cadaver; Cyclosporine; Europe; Female; Glutathione; Graft Rejection; Graft Survival; Histocompatibility; Humans; Immunosuppressive Agents; Insulin; Kidney Transplantation; Male; Middle Aged; Organ Preservation; Organ Preservation Solutions; Prognosis; Proportional Hazards Models; Public Policy; Raffinose; Solutions; Tissue and Organ Procurement; Tissue Donors; Treatment Outcome | 1996 |
Cyclosporin A-induced coronary artery vasoconstriction through myogenic and endothelium-dependent mechanisms.
Topics: Acetylcholine; Adenosine; Animals; Arginine; Coronary Circulation; Coronary Vessels; Cyclosporine; Dogs; Endothelium, Vascular; Female; Hemodynamics; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Nitroglycerin; Vasoconstriction | 1996 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
Interactions between cyclosporine A and adenosine in kidney transplant recipients.
Topics: Adenosine; Adolescent; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Vasoconstriction | 1998 |
Effects of tacrolimus and cyclosporine on the coronary microcirculation after heart transplantation: a prospective study with serial intracoronary flow measurements.
Topics: Adenosine; Blood Flow Velocity; Blood Pressure; Coronary Angiography; Coronary Circulation; Cyclosporine; Female; Heart Rate; Heart Transplantation; Hemodynamics; Humans; Immunosuppressive Agents; Male; Microcirculation; Prospective Studies; Tacrolimus; Ultrasonography | 1998 |
Modulation of long-term potentiation induction in the hippocampus by N-methyl-D-aspartate-mediated presynaptic inhibition.
Topics: Adenosine; Animals; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Enzyme Activation; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; N-Methylaspartate; Phosphoric Monoester Hydrolases; Protein Phosphatase 1; Rats; Receptors, Presynaptic; Tacrolimus | 1999 |
Late graft dysfunction after prolonged cold ischemia of the donor kidney: inhibition by cyclosporine.
Topics: Adenosine; Allopurinol; Animals; Cryopreservation; Cyclosporine; Glutathione; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Insulin; Ischemia; Kidney; Kidney Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred BN; Rats, Wistar; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1999 |
Cyclosporine A and purinergic receptors in rat kidney.
Topics: Adenosine; Animals; Blood Pressure; Calcium Channel Blockers; Cyclosporine; Female; Immunosuppressive Agents; Kidney; Nicardipine; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 1999 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Prolactin and cyclosporine modulate adenosine transporters and adenosine A1 receptors in the rat brain.
Topics: Adenosine; Animals; Brain; Carrier Proteins; Cyclosporine; Female; Hyperprolactinemia; Male; Membrane Proteins; Nucleoside Transport Proteins; Pituitary Gland, Anterior; Prolactin; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Wistar; Receptors, Purinergic P1; Thioinosine; Xanthines | 2000 |
Evaluation of potential liver donors: expanding donor criteria?
Topics: Adenosine; Adolescent; Adult; Age Factors; Allopurinol; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Glutathione; Humans; Immunosuppressive Agents; Infant; Insulin; Liver; Liver Transplantation; Methylprednisolone; Organ Preservation; Organ Preservation Solutions; Probability; Raffinose; Survival Rate; Time Factors | 2002 |
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Topics: Adenosine; Analysis of Variance; Animals; Atractyloside; Calcineurin Inhibitors; Cyclosporine; Decanoic Acids; Diazoxide; Enzyme Inhibitors; Hydroxy Acids; Ion Channels; Ischemic Preconditioning, Myocardial; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Permeability; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Calcium-Activated; Purinergic P1 Receptor Agonists; Random Allocation; Rats; Rats, Sprague-Dawley; Tacrolimus | 2002 |
Cyclosporin A and FK506 decrease adenosine kinase activity and adenosine uptake in T-lymphocytes.
Topics: Adenosine; Adenosine Kinase; Cyclosporine; Enzyme Inhibitors; Humans; Immunosuppressive Agents; In Vitro Techniques; T-Lymphocytes; Tacrolimus; Thymidine; Tritium | 2002 |
Store-operated Ca2+ entry depends on mitochondrial Ca2+ uptake.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antioxidants; Calcium; Calcium Channels; Cell Line, Tumor; Cyclosporine; Egtazic Acid; Hydrogen-Ion Concentration; Membrane Potentials; Mitochondria; Nitric Oxide; Oxygen; Patch-Clamp Techniques; Rats; Ruthenium Red; Thapsigargin; Time Factors | 2002 |
Cyclosporine enhances vasorelaxation in coronary but not pulmonary artery after 16-hour preservation with UW solution.
Topics: Adenosine; Allopurinol; Animals; Coronary Vessels; Cyclosporine; Dogs; Glutathione; Insulin; Models, Animal; Organ Preservation; Organ Preservation Solutions; Pulmonary Artery; Raffinose; Vasodilation; Vasodilator Agents | 2003 |
Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
Topics: 2,4-Dinitrophenol; Adenosine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Cardiotonic Agents; Cells, Cultured; Cyclosporine; Diazoxide; Electric Conductivity; Ion Channel Gating; Ion Channels; Ion Transport; Ischemic Preconditioning, Myocardial; Lactones; Macromolecular Substances; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Spiro Compounds; Uncoupling Agents; Vasodilator Agents | 2004 |
Cyclosporin and tacrolimus increase plasma levels of adenosine in kidney transplanted patients.
Topics: Adenosine; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2005 |
The effect of A2A adenosine receptor agonist on composite tissue allotransplant survival: an in vivo preliminary study.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Antihypertensive Agents; Cyclosporine; Cytokines; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Graft Survival; Hindlimb; Immunosuppressive Agents; Major Histocompatibility Complex; Phenethylamines; Phenotype; Rats; Rats, Inbred Lew; Receptor, Adenosine A2A; Transplantation, Homologous | 2006 |
Fluorescence assay for mitochondrial permeability transition in cardiomyocytes cultured in a microtiter plate.
Topics: Adenosine; Animals; Calcium; Cell Culture Techniques; Cells, Cultured; Cyclosporine; Fluorescence; Hydrogen-Ion Concentration; Intracellular Membranes; Luminescent Measurements; Mice; Mitochondria; Myocytes, Cardiac; Permeability; Signal Transduction | 2008 |
Cyclosporin-A does not prevent cold ischemia/reperfusion injury of rat livers.
Topics: Adenosine; Allopurinol; Animals; Apoptosis; Caspase 3; Cold Ischemia; Cyclosporine; Dimethyl Sulfoxide; Endothelium; Glutathione; Hepatocytes; Insulin; Liver; Liver Transplantation; Male; Models, Animal; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Lew; Regional Blood Flow; Reperfusion Injury | 2012 |
The role of efflux transporters on the transport of highly toxic aconitine, mesaconitine, hypaconitine, and their hydrolysates, as determined in cultured Caco-2 and transfected MDCKII cells.
Topics: Aconitine; Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Cyclosporine; Diketopiperazines; Dogs; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Madin Darby Canine Kidney Cells; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Propionates; Quinolines; Transfection; Verapamil | 2013 |
Characterization of efflux transporters involved in distribution and disposition of apixaban.
Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Cell Line, Transformed; Cell Membrane Permeability; Cyclosporine; Digoxin; Diketopiperazines; Dose-Response Relationship, Drug; Drug Interactions; Fibrinolytic Agents; Heterocyclic Compounds, 4 or More Rings; Humans; Ketoconazole; Male; Naproxen; Neoplasm Proteins; Pyrazoles; Pyridones; Rats | 2013 |
Cold storage of rat hepatocyte spheroids.
Topics: Adenosine; Albumins; Allopurinol; Ammonia; Animals; Cell Survival; Cold Temperature; Culture Media, Serum-Free; Cyclosporine; Cytochrome P-450 Enzyme System; Deferoxamine; Glutathione; Hepatocytes; Insulin; Organ Preservation Solutions; Raffinose; Rats; Spheroids, Cellular; Time Factors; Urea | 2014 |
Radioresistant Sf9 insect cells undergo an atypical form of Bax-dependent apoptosis at very high doses of γ-radiation.
Topics: Adenosine; Animals; Annexin A5; Apoptosis; bcl-2-Associated X Protein; Bongkrekic Acid; Cardiolipins; Caspase 3; Caspase 9; Cell Proliferation; Cyclosporine; DNA Fragmentation; Dose-Response Relationship, Radiation; Gamma Rays; Membrane Potentials; Mitochondrial Membranes; Oxygen; Radiation Tolerance; Reactive Oxygen Species; Sf9 Cells; Spodoptera | 2013 |
Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.
Topics: Adenosine; Antiviral Agents; Biological Assay; Cell Culture Techniques; Cell Line; Cell Survival; Cyclosporine; Furans; Genotype; Hepacivirus; Hepatitis C; High-Throughput Screening Assays; Humans; Luciferases, Renilla; Mutagenesis, Site-Directed; Oligopeptides; Pyridines; Replicon; Thiophenes; Viral Nonstructural Proteins; Virus Replication | 2014 |
Ischemic and postischemic conditioning of the myocardium in clinical practice: challenges, expectations and obstacles.
Topics: Adenosine; Cyclosporine; Enzyme Activators; Erythropoietin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nicorandil; Vasodilator Agents | 2014 |
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.
Topics: Adenosine; Cardiotonic Agents; Clinical Trials as Topic; Combined Modality Therapy; Coronary Vessels; Cyclosporine; Enzyme Inhibitors; Humans; Hypothermia, Induced; Ischemic Postconditioning; Metoprolol; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion; Myocardial Reperfusion Injury; Nitric Oxide; Nitrites; Nucleotides, Cyclic; Oligopeptides; Oximes; Patient Selection; Protein Kinase C; Secosteroids; Signal Transduction; ST Elevation Myocardial Infarction; Vasodilator Agents | 2017 |
Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man.
Topics: Adenosine; Angina Pectoris; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polypharmacy; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2018 |
Ticagrelor-induced life-threatening bleeding via the cyclosporine-mediated drug interaction: A case report.
Topics: Adenosine; Cyclosporine; Drug Interactions; Hemorrhage; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2017 |